Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Autopsy reveals rare cause of death].

Der Pathologe·2019
Same author

Mechanisms of hemolysis-associated platelet activation.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Treatment of metastatic colorectal cancer with cetuximab: influence on the quality of life.

Zeitschrift fur Gastroenterologie·2013
Same author

Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED.

International journal of impotence research·2011
Same author

Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.

Journal of thrombosis and haemostasis : JTH·2010
Same author

[Lymphoceles after radical retropubic prostatectomy. A treatment algorithm].

Der Urologe. Ausg. A·2010
Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022
Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022
Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022
Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022
Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022
Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022
See all related articles

Related Experiment Video

Updated: Feb 26, 2026

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

47.8K

[Female prostate cancer?]

S Thum1, B Haben2, G Christ3

  • 1Institut für Pathologie, St. Agnes-Hospital Bocholt, Barloer Weg 125, 46397, Bocholt, Deutschland. stefanie-thum@gmx.de.

Der Pathologe
|July 22, 2017
PubMed
Summary
This summary is machine-generated.

A rare case of Skene's gland adenocarcinoma, a type of prostate cancer, was diagnosed in a female patient. This finding challenges typical cancer diagnoses and highlights the importance of thorough histopathological examination.

Keywords:
Primary specific antigenPrimary urethral adenocarcinomaProstate carcinomaSalivary duct carcinomaSkene’s gland adenocarcinoma

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.9K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K

Related Experiment Videos

Last Updated: Feb 26, 2026

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

47.8K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.9K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K

Area of Science:

  • Uro-oncology
  • Pathology
  • Genitourinary Cancer Research

Background:

  • Urothelial carcinoma is a common malignancy of the urinary tract.
  • Skene's gland adenocarcinoma is an exceptionally rare cancer in females, often misdiagnosed.

Observation:

  • A female patient presented with clinical suspicion of advanced urothelial carcinoma of the urethra.
  • Initial clinical suspicion was based on symptoms related to the urethra.

Findings:

  • Histopathological examination revealed a malignant tumor distinct from urothelial carcinoma.
  • Morphological and immunohistochemical analyses confirmed features consistent with prostate cancer.
  • The diagnosis was established as Skene's gland adenocarcinoma.

Implications:

  • This case underscores the diagnostic challenges in rare genitourinary malignancies.
  • Accurate diagnosis requires comprehensive histopathological and immunohistochemical evaluation.
  • Further research into Skene's gland adenocarcinoma is warranted to understand its pathogenesis and improve patient outcomes.